A Single Center, Randomized, Double-blind, Parallel-design Study to Investigate the Safety and Tolerability of RO4995819 in Combination With Citalopram Following Oral Administration in Healthy Volunteers

Trial Profile

A Single Center, Randomized, Double-blind, Parallel-design Study to Investigate the Safety and Tolerability of RO4995819 in Combination With Citalopram Following Oral Administration in Healthy Volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 10 Jun 2016

At a glance

  • Drugs Decoglurant (Primary) ; Citalopram
  • Indications Major depressive disorder
  • Focus Adverse reactions
  • Sponsors Roche
  • Most Recent Events

    • 10 Jun 2016 Change in the study design, parallel assignment has been added.
    • 15 Feb 2012 Actual end date changed from Oct 2011 to Jan 2012 as reported by ClinicalTrials.gov.
    • 15 Nov 2011 Actual end date (October 2011) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top